Phreesia (NYSE:PHR) Insider Sells $91,372.04 in Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 10,063 shares of the stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $9.08, for a total value of $91,372.04. Following the transaction, the insider directly owned 25,991 shares in the company, valued at approximately $235,998.28. This represents a 27.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Phreesia Trading Up 0.1%

Shares of Phreesia stock opened at $9.18 on Monday. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The firm has a market cap of $557.47 million, a PE ratio of 305.83 and a beta of 0.86. The business’s fifty day moving average is $10.94 and its two-hundred day moving average is $16.20. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, March 30th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The business had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. During the same period in the prior year, the company earned ($0.11) EPS. The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. Analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Phreesia by 8.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock worth $134,177,000 after buying an additional 437,462 shares during the period. New York State Common Retirement Fund raised its position in shares of Phreesia by 727.1% in the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock worth $3,219,000 after buying an additional 120,309 shares during the period. Squarepoint Ops LLC raised its position in Phreesia by 243.6% in the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after purchasing an additional 71,553 shares during the period. Greenhouse Funds LLLP raised its position in Phreesia by 16.8% in the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after purchasing an additional 557,265 shares during the period. Finally, Bessemer Group Inc. raised its position in Phreesia by 1,065.9% in the third quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after purchasing an additional 506,954 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on PHR. Truist Financial reissued a “hold” rating and set a $11.00 price target (down from $24.00) on shares of Phreesia in a research note on Tuesday, March 31st. BMO Capital Markets cut their target price on Phreesia from $32.00 to $14.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 31st. Wells Fargo & Company cut their target price on Phreesia from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, March 26th. KeyCorp cut their target price on Phreesia from $15.00 to $12.00 and set an “overweight” rating on the stock in a research report on Monday, April 13th. Finally, Needham & Company LLC cut their target price on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, March 31st. Twelve investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Phreesia has a consensus rating of “Moderate Buy” and a consensus target price of $20.82.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.